Glenmark Life Sciences Ltd

NSE :GLS   BSE :543322  Sector : Pharmaceuticals
Buy, Sell or Hold GLS? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

25 Apr
750.50
(-9.20%)
24 Apr
826.50
(0.03%)
23 Apr
826.25
(-1.58%)
22 Apr
839.55
(4.60%)
19 Apr
802.65
(0.33%)
18 Apr
800.00
(0.00%)
16 Apr
800.00
(1.13%)
15 Apr
791.10
(-2.20%)
12 Apr
808.90
(-1.01%)
10 Apr
817.15
(0.47%)
09 Apr
813.30
(0.35%)
08 Apr
810.50
(-0.83%)
05 Apr
817.30
(0.24%)
04 Apr
815.35
(2.30%)
03 Apr
797.00
(0.80%)
02 Apr
790.65
(0.71%)
01 Apr
785.05
(1.08%)
28 Mar
776.65
(0.79%)
27 Mar
770.55
(1.42%)
26 Mar
759.75
(0.80%)
22 Mar
753.70
(0.46%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Neutral
Medium Term Investors

Very Bearish
Long Term Investors

Bullish

Moving Averages

5 DMA
Bearish

809.49

10 DMA
Bearish

806.28

20 DMA
Bearish

800.12

50 DMA
Bearish

807.53

100 DMA
Bearish

767.09

200 DMA
Bullish

697.35


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 25, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 894.54 863.07 774.63 - -
R2 863.07 829.55 766.59 856.86 -
R1 806.79 808.84 758.54 794.37 834.93
P 775.32 775.32 775.32 769.11 789.39
S1 719.04 741.8 742.46 706.62 747.18
S2 687.57 721.09 734.41 681.36 -
S3 631.29 687.57 726.37 - -

Key Metrics

Shareholding Pattern

  82.85% Total Promoter Holding
0.93% Mutual Fund Holdings
5.01% FIIs
10.73% Non Institution
0% Insurance Companies
0% Custodians
0.48% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Glenmark Life Sciences Ltd Quaterly Results


INCOME
PROFIT
EPS

Glenmark Life Sciences Ltd Quaterly Results


INCOME 624.16 580.3 600.73 574.5 539.73
PROFIT 146.36 135.45 118.74 118.77 97.94
EPS 11.94 11.05 9.69 9.69 7.99

Profit & Loss (Figures in Rs. Crores)


Glenmark Life Sciences Ltd Profit & Loss


INCOME
PROFIT
EPS

Glenmark Life Sciences Ltd Profit & Loss


Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 0.2 1188.45 1553.94 1956.68 2096.59 2274.62
PROFIT -0.43 196.13 314.01 352.02 419.27 467.37
EPS -434 997.92 1597.44 358.76 34.17 38.11

Balance Sheet (Figures in Rs. Crores)
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :
Share Capital 24.5124.511.961.961.960.01
Reserves Total 2,113.72,029.81750.79399.7386.17-1.41
Total Shareholders Funds2,138.212,054.32752.75401.6988.13-1.4
Unsecured Loans 19.362.8800.020.020
Total Debt19.362.8800.020.020
Total Liabilities2,157.572,057.2752.75401.7188.15-1.4
APPLICATION OF FUNDS :
Gross Block 936.48705.53651.9594.82475.570
Less : Accumulated Depreciation 155.85115.7779.148.5819.260
Net Block 780.63589.76572.8546.24456.310
Capital Work in Progress61.6296.9614.110.7380.390
Investments 0.080.080.080.080.080
Inventories 604.17516.24513.42412.78400.840.04
Sundry Debtors 806.77673.49619.5638.63448.090.03
Cash and Bank Balance309.4512.16115.6102.060.01
Loans and Advances 130.0162.69150.5298.7179.70.01
Total Current Assets1,850.341,764.591,399.041,160.12930.690.08
Current Liabilities 479.53355.881,187.851,285.11,3641.47
Provisions 22.6226.4433.622.3416.40.01
Total Current Liabilities & Provisions502.15382.321,221.441,307.441,380.391.48
Net Current Assets1,348.21,382.27177.59-147.33-449.7-1.4
Deferred Tax Assets1.811.072.030.132.290
Deferred Tax Liability44.2532.5724.9116.589.140
Net Deferred Tax-42.44-31.5-22.88-16.45-6.850
Other Assets9.4919.6311.068.447.920
Total Assets2,157.582,057.2752.75401.7288.15-1.4
Contingent Liabilities2.222.222.222.222.760

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...628.61
Depreciation42.09
Interest (Net)-15.22
P/L on Sales of Assets0.56
Prov. and W/O (Net)3.81
P/L in Forex0.89
Total Adjustments (PBT and Ext...35.32
Operating Profit before Workin...663.93
Trade and 0ther Receivables-207.21
Inventories-87.93
Trade Payables98.18
Total Adjustments (OP before W...-196.96
Cash Generated from/(used in) ...466.97
Direct Taxes Paid-153.57
Total Adjustments(Cash Generat...-153.57
Cash Flow before Extraordinary...313.4
Net Cash from Operating Activi...313.4
Purchased of Fixed Assets-170.2
Sale of Fixed Assets0.17
Interest Received15.77
Net Cash used in Investing Act...-154.15
Of Financial Liabilities-1.64
Dividend Paid-385.92
Interest Paid-0.03
Net Cash used in Financing Act...-387.59

Company Details

Registered Office
AddressPlot No. 170-172 Chandramouli,
Industrial Est.Mohol Bazarpeth
CitySolapur
StateMaharashtra
Pin Code413213
Tel. No.91-2189-234456/234246
Fax. No.
Emailcomplianceofficer@glenmarklifesciences.com
Internethttp://www.glenmarklifesciences.com
Registrars
AddressPlot No. 170-172 Chandramouli
CitySolapur
StateMaharashtra
Pin Code413213
Tel. No.91-2189-234456/234246
Fax. No.
Emailcomplianceofficer@glenmarklifesciences.com
Internethttp://www.glenmarklifesciences.com
Management
Name Designation
Glenn SaldanhaChairman & Non Executive Dir.
V S ManiNon Executive Director
Yasir Yusufali RawjeeManaging Director & CEO
Vinod NaikE D & Wholetime Director
Sridhar GorthiIndependent Non Exe. Director
Manju AgarwalIndependent Non Exe. Director
Taruvai Laxminarayanan EaswarIndependent Non Exe. Director
Gita NayyarIndependent Non Exe. Director